GTS SECURITIES LLC
Broker-DealerPosition in TLX — Telix Pharmaceuticals Ltd
CIK 1452765
NEW YORK, NY
Position in TLX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$409,741
New position
Shares Held
35,537
first reported quarter
Ownership
0.010%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#20
of 62 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026GTS SECURITIES LLC holds $5,249,889 across 19 Biotechnology names. TLX ranks #6 (7.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
1,164 | $1,079,924 | |
| 2 | GMAB |
Genmab A/S
|
32,116 | $882,226 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,060 | $526,533 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,452 | $437,095 | |
| 5 | TBPH |
Theravance Biopharma, Inc.
|
25,320 | $430,440 | |
| 6 | TLX |
Telix Pharmaceuticals Ltd
This page
|
35,537 | $409,741 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
626 | $390,336 | |
| 8 | BHVN |
Biohaven Ltd.
|
16,988 | $252,781 |
All Filings in TLX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $409,741 | 35,537 | Shares | Defined | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||